Key features:

• Make an appointment at a convenient time for you, without waiting for us to call you back.
• Appointments may book up quickly.
• If you are eligible, you can schedule an appointment.
• Only available for individuals that have used Marshfield Clinic Health System services.
• Please cancel your appointment if you get your vaccine elsewhere.

Book your COVID-19 vaccine appointment online by clicking the “Get COVID Vaccine” button on your My Marshfield Clinic account via our website or mobile app.

Start here

Don’t have a My Marshfield Clinic account? Go here and click “Register Now” on the left side.

A limited number of COVID-19 vaccine appointments may be available via My Marshfield Clinic due to vaccine supply. Check back often to find additional appointment times.

Key features:

• If you are eligible, get your vaccine during walk-in times.
• No appointment needed, but limited number of vaccines. Once we are out of vaccine, walk-in clinic will close.
• Will need to watch for dates and times of walk-in clinics.

At select locations, walk-in clinics are available. To view upcoming walk-in clinics, check out our walk-in clinic calendar. A limited supply of the COVID-19 vaccine is available at this time.

Start here

Key features:

• We will contact you when we have your vaccine.
• A vaccine will be available to you at the time of your scheduled appointment. No need to wait in line or take a chance that a vaccine may not be available.
• No need to contact us if you get your vaccine elsewhere.

Complete our form to request an appointment. We will contact you when a vaccine is available for your eligibility group. A limited supply of the COVID-19 vaccine is available at this time.

Start here

Key features:

• Call Monday-Friday, 8 a.m. to 5 p.m. to schedule a COVID-19 vaccine appointment. During all other times, please leave a message and we will contact you to schedule your appointment.
• A vaccine will be available to you at the time of your scheduled appointment. No need to wait in line or take a chance that a vaccine may not be available.
• No need to contact us if you get your vaccine elsewhere.

Book your COVID-19 vaccine appointment instantly by calling us Monday-Friday, 8 a.m. to 5 p.m.

Call 877-998-0880

• There are no reported serious safety concerns from either vaccine. All approved vaccines have gone through extensive clinical trials. The vaccine’s safety and efficacy have also been reviewed by two panels of independent experts at the FDA. While the vaccine did go through the clinical trial process quickly, it was tested on thousands of people just like every other vaccine or treatment that needs to be approved by the FDA. The shorter timeframe for vaccine development was achieved by reducing the time between each phase of the clinical trials.

• The Pfizer COVID-19 vaccine is 95% effective against symptomatic COVID-19. Protection is high even in older adults and people with chronic diseases. There is some evidence the vaccine also protects against severe COVID-19. Protection continues at a high level for at least 3-4 months. We do not yet know if protection will decline over time or if a booster dose will be needed.
• The Moderna COVID-19 vaccine is 94% effective against symptomatic COVID-19. Protection is high even in older adults and people with chronic diseases. There is some evidence the vaccine also protects against severe COVID-19. Protection continues at a high level for at least 3-4 months. We do not yet know if protection will decline over time or if a booster dose will be needed.
• The Janssen (Johnson & Johnson) COVID-19 vaccine is 66% effective against symptomatic COVID-19. Protection is high even in older adults and people with chronic diseases. The Janssen (Johnson & Johnson) COVID-19 vaccine is 85% effective in preventing severe COVID-19. Protection continues at a high level for at least 3-4 months. We do not yet know if protection will decline over time or if a booster dose will be needed.

• The vaccine has been tested on tens of thousands of people in initial clinical trials. No serious safety concerns were reported in these trials. However, more monitoring is needed to better understand if there are any long term side effects beyond the timeframe of the clinical trials. Ongoing safety monitoring through existing programs will continue to address safety concerns with the vaccine in real-time. The programs include the Vaccine Safety Datalink, Clinical Safety Assessment project, Vaccine Adverse Event Reporting Systems and new monitoring systems such as the V-SAFE program and the National Healthcare Safety Network.
• On April 13, 2021, the CDC and FDA recommended the U.S. pauses the use of the Janssen (Johnson & Johnson) COVID-19 vaccine to investigate six reported U.S. cases of rare and severe blood clots that may be linked to the Janssen COVID-19 vaccine. This recommended pause has now been lifted following the FDA and CDC's thorough safety review. Marshfield Clinic Health System will resume issuing the Janssen (Johnson & Johnson) COVID-19 vaccine at limited sites. Learn more here.

• Pain at the injection site is common and many people develop symptoms such as fatigue, headache, chills and muscle aches. These are mild to moderate in most people and typically resolve after 1-2 days. Lymph nodes may also become swollen and tender on the same side as the injection. These side effects occur because the immune system is responding normally to the vaccine. In general, these side effects are more severe after the second dose, and they may be less severe in older adults.

• While the vaccine was developed quickly, no corners were cut for the development of the vaccine. Fortunately, previous clinical research for SARS and MERS was able to be used as the vaccine was being developed to shorten the timeline. Clinical trials were also overlapped and the production of the vaccine happened prior to the completion of the vaccine. A pharmaceutical company would have never taken a risk like this had the federal government not provided incentives to do so. Finally, the FDA was able to give the vaccines emergency use authorization based on the importance of the vaccine before it is officially approved.

• All available vaccines currently provide a similar level of protection and safety. We feel there is not a better vaccine for patients. Learn more here.